Posted October 02, 2018 07:02:36The NHS has been inundated with requests for blood pressure monitors to help treat patients with hypertension, and to prevent the spread of disease.
Now, researchers from the University of Manchester are developing a device that could one day be fitted to a patient’s home.
The new device is called Tylenol, and is based on an existing sensor used in the NHS to monitor blood pressure.
It can be fitted onto the wrist and is made up of a metal casing and a sensor that can measure blood pressure and temperature.
The sensors can be adjusted to detect the amount of oxygen available to the blood vessels.
“If you want to give people the option of doing their own monitoring, the sensor is the best solution,” said Dr John Cockerham, the lead researcher.
“But it’s a complex piece of technology that’s expensive, it’s quite complex to work with, and it requires a lot of engineering expertise.”
Dr Cockeringham and his team have now built a prototype device that can be installed into a patient, and can be used to monitor a range of blood pressure parameters in a matter of minutes.
They are currently working with the device manufacturer to improve the device’s software, and hope to have it ready for commercialisation by 2019.
“The sensor is designed to be self-contained, so there is no need to have any external components in the device,” said Professor Paul McArthur, the director of the UK Centre for Blood Pressure and Circulation Research.
Professor McArthur also added that the device could be used as a health monitoring tool for those who cannot afford it. “
Its very simple to use, and the sensor will take the pressure data that we collect in the home and send it to the device.”
Professor McArthur also added that the device could be used as a health monitoring tool for those who cannot afford it.
“You can send the data to a laptop, tablet, phone or any other device,” he said.
“In this case, it will send a pulse and pulse wave that you can use to measure the blood pressure.”
Dr John McArthur is a lead researcher in the TylenoL blood pressure sensor project.
Tylenols sensors are made up entirely of a silicon chip and can detect the pressure of the blood.
It has a diameter of 1 millimetre and a diameter which can be calibrated to the exact measurement.
This is achieved by adding pressure sensors, which can then measure the pressure in the blood as well.
“We can get very accurate readings of the pressure from a single device, but with an additional device there’s a whole range of problems that can arise,” said McArthur.
“When the pressure is high enough, you can get a pulse wave.
When you add a sensor, the voltage in the sensor goes up, and if that increases, the pressure drops.
So it becomes very sensitive to that, and this can make it very difficult to detect low pressure.”
Prof McArthur added that TylenOL sensors were used in medical centres for testing, and were used by hospitals to monitor patients’ blood pressure before they left the hospital.
“There are a lot more devices out there now, but we have been working with this one to see how we can improve it,” he explained.
“What we’ve done with it is we’ve made a whole bunch of small improvements, and now we’re ready to go to commercialisation.”
The Tyleniol blood pressure instrument is being tested in the UK, with trials in the US, Australia and China expected to follow soon.
Dr Cocks, who has been working on the Tyrenol project for over a decade, said the device would be a boon to those who needed to monitor their blood pressure on the go.
“I would like to see this in all hospitals,” he told MTV News.
Professor Cockerhal’s research has been funded by the UK Department of Health and Clinical Excellence (DHCE), the European Union’s National Health Research Fund (NHRF), the Australian Department of Scientific and Industrial Research (ADOSTR), the University Hospitals of Manchester and the UK’s National Institute for Health Research (NIHR). “
For a hospital, it could be really handy for monitoring patients’ pressure every time they go to bed.”
Professor Cockerhal’s research has been funded by the UK Department of Health and Clinical Excellence (DHCE), the European Union’s National Health Research Fund (NHRF), the Australian Department of Scientific and Industrial Research (ADOSTR), the University Hospitals of Manchester and the UK’s National Institute for Health Research (NIHR).
He is currently looking at commercialisation opportunities.
The Tylinol blood sensor was developed by the University and is now being made by the NHS, and has been tested by doctors in the United Kingdom, Australia, New Zealand, France, South Korea, Japan and Spain.
TylinOL is now available for pre-order at Tylenoil.com.